封面
市场调查报告书
商品编码
1466372

切片检查设备市场:按产品、技术、应用和最终用户划分 - 全球预测 2024-2030

Biopsy Devices Market by Product (Biopsy Forceps, Localization Wires, Needle-Based Biopsy Instruments), Technique (Image Guided Biopsy, Non-Image Guided Biopsy), Application, End User - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

切片检查设备市场规模预计2023年为94.7亿美元,2024年达到104.6亿美元,预计2030年将达到194.6亿美元,复合年增长率为10.82%。

切片检查装置专门用于诊断程序,提取细胞或组织样本进行测试,以确定疾病的存在或程度。这些设备包括针头、切片检查引导系统、切片检查钳等。切片检查设备在与疾病检测和监测相关的多种医疗应用中发挥重要作用,包括乳房切片、胃肠道切片检查、前列腺切片检查、切片检查和肺部切片检查。全球癌症发生率的增加和对微创手术的偏好是推动市场成长的关键因素。相较之下,高昂的设备成本、与切片检查程序相关的风险以及医疗当局严格的监管障碍正在阻碍市场成长。然而,多家供应商正在集中研究和开发努力来克服这些问题。此外,切片检查设备製造流程的进步、切片检查设备在研究和组织库中的使用增加、医疗保健基础设施的改善以及对新兴国家的投资都有助于市场扩张。

主要市场统计
基准年[2023] 94.7亿美元
预测年份 [2024] 104.6亿美元
预测年份 [2030] 194.6亿美元
复合年增长率(%) 10.82%

由于产品併发症的风险最小化,人们对针式切片检查设备的偏好增加

切片检查钳是微创手术中使用的复杂手持式仪器,具有两瓣结构。定位线可作为确定切片检查正确部位的指南,尤其是在乳房切片过程中。它用于术前隔离乳房X光摄影或超音波中检测到的不可触及的病变,确保准确性并协助放射科医生获取组织标本。对于深部病变,首选针吸活检装置,常见类型包括细针穿刺活检和粗针穿刺切片。众所周知,这些仪器可以减少手术併发症并有效收集高品质样本,有助于准确诊断。针式切片检查装置包括抽吸针、核心切片检查装置和真空辅助切片检查装置。抽吸针在细针抽吸切片检查中发挥重要作用,细针抽吸活检用于检查肿块和肿块。核心切片检查装置可取出小组织切片进行病理检查,通常用于乳房、肝臟和骨骼切片检查。真空辅助主题是微创切片检查手术的高效工具。该装置采用真空机制,可连续采集组织样本,而无需重新插入针头。手术托盘是一个紧凑、系统化的解决方案,适用于特定手术所需的所有切片检查仪器。优化工作流程,促进资源高效利用,并提高程序无菌性。

技术MRI引导切片检查在实现高诊断准确性的切片检查设备中的重要作用

影像引导切片检查是切片检查设备领域的显着创新,它利用了现代成像技术的精确度。这项先进技术使医生能够从难以进​​入的区域采集样本,从而实现更精确、侵入性更小的手术。影像引导切片检查包括MRI引导切片检查、立体定位切片检查和超音波引导切片检查。 MRI 导引切片检查已成为诊断难以到达区域或更复杂结构(例如大脑或乳房)异常的首选程序。立体定位切片检查更容易应用于相对表面的异常,例如靠近乳房或皮肤的病灶。此手术的优点是确保患者准确诊断,同时避免侵入性手术带来的不适。超音波引导切片检查是颈部、胸部和腹部切片检查的首选,主要是因为其具有提供即时影像的优势。此外,超音波引导切片检查具有成本效益,并且可以更快地进行切片检查,这使得它们在成本和时间是主要考虑因素的情况下成为首选。相较之下,MRI引导切片检查在晚期病例中处于领先地位,浅表病例需要立体定位切片检查环,而超音波引导切片检查具有即时性要求和成本效益,已被证明在多种情况下是有益的。非影像导引切片检查涉及使用触诊和解剖标誌来确定切片检查部位的技术,无需真实影像引导的帮助。影像切片检查和非影像导引切片检查之间的选择很大程度上取决于病变的位置和性质、患者的健康状况和可用资源。影像引导切片检查在准确性和安全性方面具有广阔的前景,特别是对于不可触及的病变和深部病变。然而,对于表浅肿块,非影像导引切片检查仍然是一种快速且经济高效的选择。

应用 由于乳癌和摄护腺癌的癌症发生率不断增加,对切片检查设备的需求不断增加

随着世界各地乳癌患者数量的增加,对乳房切片检查设备的需求也增加。真空辅助切片检查(VAB) 系统等设备因其微创、可靠的诊断以及快速无痛的过程而越来越受欢迎。柔性乙状结肠镜是结肠切片检查的首选,因为它们可以检测直肠和乙状结肠的异常情况。包括癌症在内的肺部疾病的盛行率不断增加,引发了对切片检查设备的需求,其中常用的是经胸针活检(TTNB)设备。对于摄护腺切片检查,主要使用经直肠超音波(TRUS)引导的摄护腺切片检查切片检查装置。随着癌症发生率的增加,用于乳房和前列腺切片检查的切片检查装置经历了重大的技术进步。同时,用于切片检查和结肠切片检查的设备可用于多种疾病,包括癌症。切片检查设备在医学诊断中至关重要,反映了不断进步并确保患者健康。

最终使用者:增加切片检查设备的使用,以加快医院的復健速度

学术和研究机构寻求创新的解决方案来提高切片检查程序的准确性和效率,特别关注非侵入性程序。这些研究机构正在寻求先进、先进的切片检查设备,以开拓医学研究的新领域。诊断中心和影像诊断中心着重及时、准确的诊断。这些设施需要切片检查装置,以最大限度地减少患者的不适并允许快速采集样本。切片检查设备可实现更短的恢復时间、更少的併发症和更低的成本,是主要关注患者安全、舒适和成本效益的初级医疗保健提供者和医院的理想选择。这些使用者群体的通用目标是提高切片检查程序的准确性和效率。不同的产业需要推动市场发展,带来更细緻的创新并改善全球健康。

区域洞察

在美洲,由于各种癌症患者的增加,切片检查设备的使用正在增加。根据美国癌症协会估计,2023 年将有 1,958,310 例新癌症病例。这与切片检查设备的需求直接相关。最尖端科技和医疗进步以及该地区有利的报销政策正在促进市场成长。此外,人们对癌症早期检测的认识不断提高,再加上强有力的医疗保健行销,这为该地区切片检查设备的更多使用铺平了道路。此外,欧洲、中东和非洲地区对切片检查设备的需求很高,该地区的特点是人口迅速老化和癌症发病率高。技术先进的医疗设备和基础设施的引进也推动了市场的涌入。该地区的国家医疗保健系统促进了及时、准确的癌症诊断,并扩大了切片检查设备的使用范围。世界卫生组织 (WHO) 和欧洲肿瘤研究所进行的宣传宣传活动刺激了该地区对切片检查设备的需求。此外,包括癌症文明病在亚太地区正在迅速增加。人口老化、环境污染和不健康的生活方式正在增加癌症的发生率,并增加对切片检查设备的需求。此外,医疗保健系统的改善、医疗成本的上升以及对早期癌症检测的认识的提高也是推动切片检查设备采用的因素。

FPNV定位矩阵

FPNV 定位矩阵对于评估切片检查设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市场占有率分析

市场占有率分析是一种综合工具,可以对切片检查设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解:

1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。

3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题:

1.切片检查设备市场的市场规模和预测是多少?

2.在切片检查设备市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些?

3.切片检查设备市场的技术趋势和法规结构是什么?

4.切片检查设备市场主要供应商的市场占有率是多少?

5. 进入切片检查设备市场的适当型态和策略手段是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症和胃肠道疾病的发生率增加
      • 更多采用微创技术
      • 提高人们对早期疾病检测和筛检重要性的认识
    • 抑制因素
      • 生产切片检查装置的成本很高。
    • 机会
      • 切片检查设备的持续技术进步
      • 液体切片检查设备的成长趋势
    • 任务
      • 卫生当局严格监管的问题
  • 市场区隔分析
    • 产品:由于併发症风险最小,人们越来越偏好针式切片检查装置。
    • 技术:MRI引导切片检查在切片检查设备中发挥重要作用,以实现高诊断准确性
    • 用途:由于乳癌和摄护腺癌病例的增加,对乳癌和摄护腺癌的需求也在增加。
    • 最终用户:提高切片检查设备的利用率,以加快医院的恢復速度
  • 市场趋势分析
    • 再加上美洲大公司的强大影响力,开发新型切片检查设备的研究活动正在增加。
    • 由于区域监管机构的产品核可增加以及研发活动的扩大,亚太地区切片检查设备的应用不断扩大
    • 欧洲、中东和非洲地区先进的医疗设施以及癌症检测和预防计划
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章切片检查设备市场:副产品

  • 切片检查钳
  • 定位线
  • 针切片检查仪器
  • 治疗托盘

第七章切片检查设备市场:依技术分类

  • 影像引导切片检查
  • 非影像引导切片检查

第八章切片检查设备市场:按应用

  • 骨髓切片检查
  • 乳房切片
  • 切片检查
  • 切片检查
  • 摄护腺切片检查

第 9 章切片检查设备市场:按最终用户分类

  • 学术研究所
  • 诊断/影像诊断中心
  • 医院

第10章美洲切片检查设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太切片检查设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲切片检查设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • LUMINELLE宣布中国国家智慧财产局决定授予LUMINELLE Bx(切片检查)系统专利,扩大全球扩张
    • Limaca Medical 突破性精密胃肠内切片检查设备获得 FDA 510(k) 许可
    • 史赛克 (Stryker) 宣布推出具有颅脑引导软体的 Q 引导系统
    • Merit Medical 收购 Angiodynamics 导管产品组合和切片检查系统
    • Argon SuperCore Advantage切片检查设备在美国推出
    • Quest Diagnostics 收购 Haystack Oncology,将敏感液态生物检体技术添加到其肿瘤产品组合中,以改善个人化癌症治疗
    • Innovia Medical 在 BACO International 2023 上推出口腔旋转切片检查打孔器
    • Guardant360 CDx 获得 FDA核准作为 ORSERDU 的伴同性诊断
    • TransMed7 LLC 宣布 SpeedBird 乳房切片检查设备在商业发布前首次临床使用
    • Terumo Corporation India 与 Argon Medical 合作扩大产品组合

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-4103B31E073F

[183 Pages Report] The Biopsy Devices Market size was estimated at USD 9.47 billion in 2023 and expected to reach USD 10.46 billion in 2024, at a CAGR 10.82% to reach USD 19.46 billion by 2030.

The biopsy devices are used explicitly in diagnostic procedures that involve the extraction of sample cells and tissues for examination aimed at identifying the existence and extent of a disease. These devices range from needle biopsy devices, biopsy guidance systems to biopsy forceps. Biopsy devices have a crucial role in several medical applications pertaining to disease detection and monitoring, including breast biopsy, gastrointestinal biopsy, prostate biopsy, liver biopsy, and lung biopsy. An increasing prevalence of cancer worldwide and a growing preference for minimally invasive surgeries are pivotal factors driving the market growth. In contrast, high equipment costs, risks associated with biopsy procedures, and the stringent regulatory hurdles by health authorities hinder the market growth. However, several vendors are focusing on R&D to overcome these issues. Furthermore, advancements in the manufacturing process of biopsy devices, extending the usage of biopsy devices in research and tissue banking, improved healthcare infrastructures, and investments in emerging economies contribute to market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 9.47 billion
Estimated Year [2024] USD 10.46 billion
Forecast Year [2030] USD 19.46 billion
CAGR (%) 10.82%

Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications

Biopsy forceps are sophisticated, hand-held devices used during minimally invasive procedures, designed with a two-leaf structure; they are adept at extracting tissue samples from targeted areas with sheer precision and minimal patient discomfort. Localization wires act as a guide in identifying the correct area for biopsy, particularly in breast biopsy procedures. They are used preoperatively to seperate non-palpable lesions detected during mammography or ultrasound, ensuring precision and aiding radiologists in obtaining tissue samples. Needle-based biopsy instruments are preferred for deep-seated lesions; common types include fine-needle aspiration and core-needle biopsies. These devices reduce procedural complications and are known for their efficiency in obtaining high-quality samples, helping in precise diagnoses. Needle-based biopsy instruments include aspiration needles, core biopsy devices, and vacuum-assisted biopsy devices. Aspiration needles play a crucial role in fine-needle aspiration biopsy procedures, often used to investigate lumps or masses. Core biopsy devices remove a small tissue section for pathological examination, usually used in breast, liver, or bone biopsies. Vacuum-assisted biopsy devices are remarkably efficient tools for minimally invasive biopsy procedures. Employing a vacuum mechanism, these devices allow for a continuous tissue sample to be acquired without reinserting the needle. Procedure trays are a compact, systematic solution encompassing all necessary biopsy tools for a specific procedure. They optimize the workflow, promote efficient resource use, and enhance the sterility of the procedure.

Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy

Image-guided biopsy is a noteworthy innovation in the realm of biopsy devices, harnessing the precision of modern imaging technologies. This advanced technique enables doctors to extract samples from difficult-to-access areas, leading to a more accurate and less invasive procedure. Image-guided biopsy includes MRI-guided biopsy, stereotactic-guided biopsies, and ultrasound-guided biopsy. MRI-guided biopsy has become a preferred technique for diagnosing abnormalities located in difficult-to-reach areas or those of more intricate structures such as the brain and the breast. Stereotactic-guided biopsies are more applicable for relatively superficial abnormalities, including those in the breast and lesions close to the skin. This technique is a boon for patients to avoid the discomfort of invasive procedures while still ensuring a highly accurate diagnosis. Ultrasound-guided biopsy primarily leverages its advantage in real-time image provision, making it the go-to option for neck, chest, and abdomen biopsies. Furthermore, it is a cost-effective and faster way of performing biopsies and is preferred in situations where cost and time are primary considerations. In comparison, MRI-guided biopsy stands at the forefront of advanced cases, stereotactic biopsy rings are necessary for superficial cases, and ultrasound-guided offerings are proven beneficial in real-time requirements and cost-effective scenarios. Non-image guided biopsy includes techniques where palpation or anatomical landmarks are used to determine the biopsy site without the assistance of live-image guidance. The choice between image-guided and non-image-guided biopsies largely depends on the location and nature of the lesion, the patient's health status, and the resources available. Image-guided biopsy methods are leading in the context of precision and safety, particularly for non-palpable and deep-seated lesions. However, non-image-guided procedures remain a fast and cost-effective option for superficial masses.

Application: Growing need for breast and prostate biopsy devices due to increasing instances of cancer in both areas

The upsurge in breast cancer cases worldwide has subsequently triggered the need for breast biopsy devices. Devices such as vacuum-assisted biopsy (VAB) systems attain favor for their minimally invasive nature, confident diagnosis, and high-speed, painless process. Flexible sigmoidoscopes are preferred for colorectal biopsy due to their ability to detect abnormalities in the rectum and sigmoid colon. The rising incidence of lung conditions, including cancer, triggers the need for lung biopsy devices, where transthoracic needle biopsy (TTNB) devices are commonly used. Prostate biopsy procedures largely use transrectal ultrasound (TRUS) guided prostate biopsy devices, as per need-based preference. Biopsy devices for breast and prostate biopsies are undergoing significant technological advancement owing to rising cancer rates. Simultaneously, devices for lung and colorectal biopsies address a range of illnesses, cancer included. Biopsy devices remain paramount in medical diagnosis, reflecting continuous progress and ensuring patient health.

End User: Rising utilization of biopsy devices that promote lesser recovery time in the hospitals

Academic and research institutes pursue innovative solutions for improving the accuracy and efficiency of biopsy procedures, with a particular emphasis on non-invasive techniques. These institutions seek sophisticated and advanced biopsy devices that allow them to explore new frontiers of medical research. Diagnostic and imaging centers focus primarily on timely and accurate diagnosis. They require biopsy devices that facilitate rapid sample collection with minimal patient discomfort. Biopsy devices that allow for shorter recovery times, fewer complications, and lower costs are ideally preferred by primary healthcare providers and hospitals as they mainly focus on patient safety, comfort, and cost-effectiveness. The shared objective across these user groups is to enhance biopsy procedure accuracy and efficiency. The varied sector needs to drive market evolution, promising more subtle innovations and improved global health outcomes.

Regional Insights

The Americas region has witnessed a rising trend in the utilization of biopsy devices due to the increase in various cancer cases. According to the American Cancer Society, in 2023, there are estimated to be 1,958,310 new cancer cases. This directly contributes to the need for biopsy devices. State-of-the-art technology and medical advancements, alongside favorable reimbursement policies in this region, contribute to the market growth. Also, growing awareness about early detection of cancer, reinforced by strong healthcare marketing, paves the path for increased use of biopsy devices in the region. Furthermore, the EMEA region, characterized by rapidly aging populations and a high incidence of cancer, has a strong need for biopsy devices. The market inflow is also credited to the adoption of technologically advanced healthcare equipment and infrastructure. National healthcare systems in this region promote timely and accurate cancer diagnosis, enabling increased biopsy device utilization. The awareness campaigns by the World Health Organization (WHO) and the European Institute of Oncology stimulate the need for biopsy devices in the region. Moreover, the APAC region is experiencing a rapid increase in lifestyle-related diseases, including cancers. The aging population, environmental pollution, and unhealthy lifestyle habits are fueling the incidences of cancer, thereby increasing the need for biopsy devices. In addition, improving healthcare systems, increasing healthcare spending, and raising awareness about early cancer detection are other factors fostering the adoption of biopsy devices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopsy Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopsy Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Axlab Limited, B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., CONMED Corporation, Cook Group Incorporated, Danaher Corporation, F. Hoffmann-La Roche Ltd., Ferrosan Medical Devices A/S, Fujifilm Holdings Corporation, Guardant Health, Inc., Hologic, Inc., Innovia Medical, INRAD, Inc., Integra LifeSciences Holdings Corporation, IZI Medical Products, LLC by Halma PLC, JEB Technologies Limited, Limaca-Medical, MediTech Devices Pvt Ltd., Medtronic PLC, Merit Medical Systems, Inc., Mermaid Medical, Olympus Corporation, PAJUNK GmbH Medizintechnologie, Remington Medical, Spectra Medical Devices, LLC, Stryker Corporation, Suretech Medical Inc., Trajan Scientific and Medical Pty Ltd., TransMed7, LLC, TSK Laboratory, UVision360, Volkmann MedizinTechnik GmbH, weLLgo Medical Products GmbH, and Zamar Care.

Market Segmentation & Coverage

This research report categorizes the Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Biopsy Forceps
    • Localization Wires
    • Needle-Based Biopsy Instruments
      • Aspiration Needles
      • Core Biopsy Devices
      • Vacuum-Assisted Biopsy Devices
    • Procedure Trays
  • Technique
    • Image Guided Biopsy
      • MRI-Guided Biopsy
      • Stereotactic-Guided Biopsy
      • Ultrasound-Guided Biopsy
    • Non-Image Guided Biopsy
  • Application
    • Bone Marrow Biopsy
    • Breast Biopsy
    • Kidney Biopsy
    • Lung Biopsy
    • Prostate Biopsy
  • End User
    • Academic & Research Institutes
    • Diagnostic & Imaging Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biopsy Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopsy Devices Market?

3. What are the technology trends and regulatory frameworks in the Biopsy Devices Market?

4. What is the market share of the leading vendors in the Biopsy Devices Market?

5. Which modes and strategic moves are suitable for entering the Biopsy Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of cancer and gastrointestinal diseases
      • 5.1.1.2. Rise in adoption of minimally-invasive techniques
      • 5.1.1.3. Increasing awareness of the importance of early detection and screening of diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the production of biopsy devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous technological advancements in biopsy devices
      • 5.1.3.2. Growing inclination towards liquid biopsy devices
    • 5.1.4. Challenges
      • 5.1.4.1. Problems associated with stringent regulations by health authorities
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications
    • 5.2.2. Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy
    • 5.2.3. Application: Growing need for breast and prostate biopsy devices due to increasing instances of cancer in both areas
    • 5.2.4. End User: Rising utilization of biopsy devices that promote lesser recovery time in the hospitals
  • 5.3. Market Trend Analysis
    • 5.3.1. Growing research activities in developing novel biopsy devices coupled with robust presence of major companies in the Americas region
    • 5.3.2. Increasing product approvals from regional regulatory bodies coupled with growing research and development activities to expand the application of biopsy devices in the APAC region
    • 5.3.3. Advanced healthcare facilities and cancer detection and prevention program in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Biopsy Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Biopsy Forceps
  • 6.3. Localization Wires
  • 6.4. Needle-Based Biopsy Instruments
  • 6.5. Procedure Trays

7. Biopsy Devices Market, by Technique

  • 7.1. Introduction
  • 7.2. Image Guided Biopsy
  • 7.3. Non-Image Guided Biopsy

8. Biopsy Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Bone Marrow Biopsy
  • 8.3. Breast Biopsy
  • 8.4. Kidney Biopsy
  • 8.5. Lung Biopsy
  • 8.6. Prostate Biopsy

9. Biopsy Devices Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Diagnostic & Imaging Centers
  • 9.4. Hospitals

10. Americas Biopsy Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biopsy Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biopsy Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. LUMINELLE Announces China National Intellectual Property Administration's Decision to Grant Issuance of Patent for LUMINELLE Bx (Biopsy) System, Expanding Global Footprint
    • 13.3.2. Limaca Medical Receives FDA 510(k) Clearance for its Breakthrough Precision GI Endoscopic Biopsy Device
    • 13.3.3. Stryker Announces Commercial Launch of Q Guidance System with Cranial Guidance Software
    • 13.3.4. Merit Medical Acquires AngioDynamics' Catheter Portfolio and Biopsy System
    • 13.3.5. Argon's SuperCore Advantage Biopsy Instrument Launched in United States
    • 13.3.6. Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
    • 13.3.7. Innovia Medical Launches the Oral Rotating Biopsy Punch at BACO International 2023
    • 13.3.8. Guardant360 CDx Gets FDA Approval as Companion Diagnostic for ORSERDU
    • 13.3.9. TransMed7, LLC Announces First Clinical Use of SpeedBird Breast Biopsy Devices for Commercial Launch
    • 13.3.10. Terumo India Partners with Argon Medical to Expand Portfolio

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BIOPSY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPSY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOPSY DEVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPSY DEVICES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIOPSY DEVICES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BIOPSY FORCEPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BIOPSY FORCEPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ASPIRATION NEEDLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ASPIRATION NEEDLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CORE BIOPSY DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CORE BIOPSY DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPSY DEVICES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BIOPSY DEVICES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPSY DEVICES MARKET SIZE, BY MRI-GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BIOPSY DEVICES MARKET SIZE, BY MRI-GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOPSY DEVICES MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BIOPSY DEVICES MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NON-IMAGE GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NON-IMAGE GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 337. FINLAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 338. FINLAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 339. FINLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. FINLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. FINLAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 342. FINLAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 343. FRANCE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. FRANCE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. FRANCE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 346. FRANCE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 347. FRANCE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 348. FRANCE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 349. FRANCE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 350. FRANCE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 351. FRANCE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 352. FRANCE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 353. FRANCE BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 354. FRANCE BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 355. GERM